thrombotest

A test of the coagulability of the blood used to monitor treatment with anticoagulant drugs. It is a modified prothrombin time test that measures Factor IX and other factors dependent on vitamin K.

References in periodicals archive ?

Thrombotest a new method for controlling anticoagulant therapy.

Capnocytophaga canimorsus Capsular Serovar and Disease Severity, Helsinki Hospital District, Finland, 2000-2017

(18) APTT, PT, Fbg, thrombotest, ATIII, [alpha]2PI, Plg, TAT, PAP, TM, PAI-1/tPA complex, protein C and protein S Kilercik et al.

Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance Specifications

Thus, in the first group pre- and post-therapy thrombotest degree was 5.27 [+ or -] 0.1 degree and 5.18 [+ or -] 0.1 degree, respectively (normal range IV-VI degree).

Pharmacogenetic efficacy of perindopril in children and adolescents with type 1 diabetes mellitus in prediction of diabetic nephropathy

The coagulation parameters (prothrombin time, PT; activated partial thromboplastin time, APTT; fibrinogen, Fbg; and thrombotest (Owren), TTO) were measured with an automated blood coagulation analyzer (CA-50; Sysmex Co., Hyogo, Japan) according to the manufacturer's protocol.

Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome p450 enzymes by bilobalide in mice

All patients had retained, and provided for data collection, a complete record of their warfarin dosage over time, and degree of anticoagulation, measured before 1984 as the Thrombotest [4] and after 1984 as the International Normalised Ratio [5].

Ten years of experience with standardization of thrombotest, according to the WHO model for ISI determination.

Effect of ageing upon warfarin dose requirements: a longitudinal study

Two money-spinners were developed in rapid succession: these were Thrombotest, a reagent and diagnostic technique for anticoagulants; and Isopaque, an X-ray contrast agent.

Wealth of Contrasts: Nyegaard & Co. - A Norwegian Pharmaceutical Company, 1874-1985

Thrombotest. A new method for controlling anticoagulant therapy.

External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials

Thrombotest: a new method for controlling anticoagulant therapy.

Discrepancies in international normalized ratio results between instruments: a model to split the variation into subcomponents

INR values of the pooled plasmas were determined with the Thrombotest reagent after heparinase treatment [151.

Preparation of lyophilized partial thromboplastin time reagent composed of synthetic phospholipids: usefulness for monitoring heparin therapy